...
首页> 外文期刊>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology >The 1 cases of robotic-assisted laparoscopic radical prostatectomy according to D'Amico risk criteria
【24h】

The 1 cases of robotic-assisted laparoscopic radical prostatectomy according to D'Amico risk criteria

机译:根据D'Amico风险标准进行机械辅助腹腔镜前列腺癌根治术1例

获取原文
获取原文并翻译 | 示例

摘要

Background: To analyze the trifecta outcome (continence, potency, and cancer control) in 300 cases of robotic-assisted laparoscopic radical prostatectomy (RARP). Methods: A prospective assessment of outcomes in 300 consecutive patients that underwent a RARP performed by a single surgeon. Patients were grouped according to D'Amico risk criteria: Group I consisted of 'low-risk' cases (n = 64), Group II consisted of 'intermediate-risk' cases (n = 88), and Group III consisted of 'high-risk' cases (n = 148). Patients were evaluated for perioperative complications and the trifecta outcome. Results: The operation time, blood loss, post-operative stay, duration of urethral catheterization, and perioperative complication rate were similar among all groups. The incidence of bilateral neurovascular bundle (NVB) preservation was significantly decreased with the increasing risk of cases (P < 0.001). The continence rates at the 1-week, 1-month, 3-month, 6-month, and 12-month follow-ups did not differ significantly between groups. The potency rates at the 12-month follow-up were not significantly different. The positive surgical margin and positive lymph node metastasis rate increased with the increasing risk of cases (P < 0.001). The biochemical recurrence rate (BCR, PSA >0.2 ng/mL) was 3.1, 11.36, and 19.59% in Groups I, II and III, respectively (P = 0.004). The trifecta outcome for RARP with bilateral NVB preservation showed no significant differences among groups. Conclusions: Undergoing a RARP is safe and feasible in high-risk prostate cancer patients. Compared to low-risk and intermediate-risk groups, the high-risk group had a significant higher incidence of positive surgical margin, positive lymph node metastasis, and BCR rate.
机译:背景:分析300例机器人辅助腹腔镜根治性前列腺切除术(RARP)的三连胜结果(节制,效力和癌症控制)。方法:由一名外科医生对300例接受RARP的连续患者进行前瞻性评估。根据D'Amico风险标准对患者进行分组:第一组由“低风险”病例(n = 64)组成,第二组由“中风险”病例(n = 88)组成,第三组由“高风险”病例组成-高风险案例(n = 148)。对患者进行围手术期并发症和三联预后评估。结果:各组的手术时间,失血量,术后停留时间,尿道插管时间和围手术期并发症发生率相似。随着病例风险的增加,双侧神经血管束(NVB)保存的发生率显着降低(P <0.001)。各组在1周,1个月,3个月,6个月和12个月的随访中的尿失禁率没有显着差异。在12个月的随访中,效价没有显着差异。阳性切缘和阳性淋巴结转移率随着病例风险的增加而增加(P <0.001)。第一,第二和第三组的生化复发率(BCR,PSA> 0.2 ng / mL)分别为3.1、11.36和19.59%(P = 0.004)。保留双侧NVB的RARP的三联结果在各组之间无显着差异。结论:在高危前列腺癌患者中进行RARP是安全可行的。与低风险和中风险组相比,高风险组的手术切缘阳性,淋巴结转移阳性和BCR发生率显着更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号